SCHEMBL4725859

SCHEMBL4725859

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)c4ccccc34)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.63
KDM4E B2RXH2 2/20 0.63
ATM Q13315 1/20 0.63
KMT2A Q03164 4/20 0.50
HDAC4 P56524 1/20 0.48
IL1R1 P14778 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 1/20 0.41
PTPN1 P18031 2/20 0.39
ACHE P22303 1/20 0.37
FAAH O00519 1/20 0.37
MGLL Q99685 1/20 0.37
AVPR1A P37288 1/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSP90AA1 P07900 1/20 0.36
EDNRB P24530 1/20 0.36
EDNRA P25101 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10098603 1.00 L3MBTL1 (0.63) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL9890892 1.00 L3MBTL1 (0.63) L3MBTL1KDM4EATMKMT2AHDAC4
Biphenyl SCHEMBL27864608 1.00 L3MBTL1 (0.63) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL36248 0.98 L3MBTL1 (0.65) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL29360041 0.98 L3MBTL1 (0.65) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL29407190 0.98 L3MBTL1 (0.65) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL13592779 0.96 L3MBTL1 (0.61) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL13286813 0.94 L3MBTL1 (0.65) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL275300 0.94 L3MBTL1 (0.64) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL15449925 0.93 L3MBTL1 (0.55) L3MBTL1KDM4EATMKMT2AHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9461251-B2 Anthracene derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2016-10-04 US disclosed
US-9461251-B2 Anthracene derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2016-10-04 US disclosed
US-8845926-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-30 US disclosed
US-8845926-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-30 US disclosed
US-8518492-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-08-27 US disclosed
US-8518492-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-08-27 US disclosed
US-8512875-B2 Anthracene derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2013-08-20 US disclosed
US-8512875-B2 Anthracene derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2013-08-20 US disclosed
US-8502201-B2 Light-emitting element TORAY INDUSTRIES, INC. (JP) 2013-08-06 US disclosed
US-8502201-B2 Light-emitting element TORAY INDUSTRIES, INC. (JP) 2013-08-06 US disclosed
US-20080286445-A1 COMPOSITION, AND METHOD OF FABRICATING LIGHT-EMITTING ELEMENT SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-20 US disclosed
US-7387845-B2 Monoamino compound and organic luminescence device using the same CANON KABUSHIKI KAISHA (JP) 2008-06-17 US disclosed
US-7387845-B2 Monoamino compound and organic luminescence device using the same CANON KABUSHIKI KAISHA (JP) 2008-06-17 US disclosed
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-05-08 US disclosed
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-05-08 US disclosed
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-05-08 US disclosed
WO-2008026614-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-03-06 WO disclosed
WO-2008026614-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-03-06 WO disclosed
US-20070247063-A1 Light-Emitting Device Material and Light-Emitting Device TORAY INDUSTRIES INC. (JP) 2007-10-25 US disclosed
US-20070247063-A1 Light-Emitting Device Material and Light-Emitting Device TORAY INDUSTRIES INC. (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070247063-A1 Light-Emitting Device Material and Light-Emitting Device CRY1, CRY2, ATXN10 L3MBTL1 530/4885KDM4E 3893/4885ATM 1395/4885
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE ALAD, CYP2C9, CYP1A1 L3MBTL1 3456/4885KDM4E 2175/4885ATM 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.